Helichrysum (Helichrysum italicum)
Helichrysum italicum, the immortelle plant, contains arzanol and flavonoids such as naringenin and kaempferol as its primary bioactive compounds. These molecules inhibit pro-inflammatory enzymes including COX-1, COX-2, and 5-lipoxygenase, driving its antioxidant and anti-inflammatory effects.
Origin & History
Helichrysum italicum, or immortelle, is a perennial shrub native to the Mediterranean, especially in Italy, France, and Croatia. It is primarily harvested for its flowering tops, from which essential oils are extracted through techniques like steam distillation and supercritical CO₂ extraction.
Historical & Cultural Context
Traditionally, Helichrysum italicum has been used in Mediterranean regions, such as Sardinia, for treating inflammatory conditions through infusions and decoctions. Its historical applications are based on its high flavonoid content.
Health Benefits
• Antioxidant properties: Preliminary in vitro studies suggest antioxidant effects due to its rich flavonoid content. • Anti-inflammatory potential: Traditionally used in Mediterranean medicine for inflammatory conditions, supported by animal studies. • Antimicrobial activities: In vitro assays indicate potential antimicrobial effects, although no human clinical data is available. • Skin health: Used traditionally for skin applications, attributed to its essential oil components. • Potential analgesic effects: Animal studies suggest pain-relieving properties, though human studies are lacking.
How It Works
Arzanol, a prenylated phloroglucinol-alpha-pyrone, directly inhibits COX-1, COX-2, and 5-LOX enzymes, suppressing prostaglandin E2 and leukotriene B4 synthesis. Flavonoids including naringenin and kaempferol scavenge reactive oxygen species and modulate NF-κB signaling, reducing transcription of pro-inflammatory cytokines such as IL-6 and TNF-alpha. Additionally, italicene and neryl acetate in the essential oil disrupt bacterial membrane integrity, contributing to antimicrobial activity.
Scientific Research
Currently, there are no human clinical trials or meta-analyses available for Helichrysum italicum. The existing studies are primarily in vitro or animal-based, focusing on its antioxidant and anti-inflammatory potential.
Clinical Summary
Evidence for Helichrysum italicum in humans remains sparse and preliminary. Most data derive from in vitro cell culture assays and rodent models, where arzanol demonstrated dose-dependent inhibition of inflammatory mediators at concentrations of 1–30 µM. One small open-label pilot study examined topical helichrysum essential oil for skin inflammation, but sample sizes were under 30 participants with no placebo control, limiting conclusions. No large randomized controlled trials have evaluated oral supplementation, making clinical efficacy claims premature.
Nutritional Profile
Helichrysum italicum (curry plant/immortelle) is used primarily as a medicinal/aromatic herb rather than a dietary staple, so macronutrient contribution is negligible in typical usage amounts. Bioactive compounds are the primary nutritional interest: Flavonoids: total flavonoid content estimated at 1.2–3.5% dry weight, dominated by naringenin (up to 0.8% dry weight), isosalipurposide, and apigenin glucosides. Phenolic acids: chlorogenic acid and caffeic acid derivatives present at approximately 0.5–1.2% dry weight. Italicene and neryl acetate are signature volatile terpene compounds comprising 10–30% of essential oil fraction (typically used at <1% concentration in food/therapeutic applications). Arzanol (a prenylated phloroglucinol-pyrone heterodimer) is a key bioactive at approximately 0.1–0.4% in aerial parts — considered the primary anti-inflammatory agent. Triterpenoids including oleanolic acid and ursolic acid are present at trace levels (~0.05–0.2% dry weight). Essential oil yield is approximately 0.1–0.5% fresh weight. Vitamins and minerals are not significantly documented in literature; fiber and protein content are negligible given typical usage quantities (culinary use as flavoring herb at <1g per serving). Bioavailability note: flavonoids from Helichrysum show moderate bioavailability; arzanol bioavailability in humans has not been formally characterized in pharmacokinetic studies to date.
Preparation & Dosage
No clinically studied dosage ranges are available for Helichrysum italicum due to the absence of human trials. Preparation ratios for extraction are reported, but lack therapeutic standardization. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Lavender, Rosemary, Chamomile, Sage, Eucalyptus
Safety & Interactions
Topical application of helichrysum essential oil is generally well tolerated, though contact dermatitis has been reported in sensitive individuals and a patch test is advisable before widespread use. Oral supplementation safety data in humans are insufficient, and high-dose arzanol may theoretically potentiate anticoagulant drugs such as warfarin due to COX inhibition reducing platelet aggregation. Helichrysum should be avoided during pregnancy and lactation given the absence of safety data in these populations. Individuals with allergies to Asteraceae family plants, including ragweed and chrysanthemums, face an elevated cross-reactivity risk.